Emodic acid
Internal ID | 21eca013-2560-4173-bec9-ee3fb322c933 |
Taxonomy | Benzenoids > Anthracenes > Anthracenecarboxylic acids and derivatives > Anthracenecarboxylic acids |
IUPAC Name | 4,5,7-trihydroxy-9,10-dioxoanthracene-2-carboxylic acid |
SMILES (Canonical) | C1=C(C=C(C2=C1C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O)C(=O)O |
SMILES (Isomeric) | C1=C(C=C(C2=C1C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O)C(=O)O |
InChI | InChI=1S/C15H8O7/c16-6-3-8-12(10(18)4-6)14(20)11-7(13(8)19)1-5(15(21)22)2-9(11)17/h1-4,16-18H,(H,21,22) |
InChI Key | ZJXVNNSMRGTDBI-UHFFFAOYSA-N |
Popularity | 17 references in papers |
Molecular Formula | C15H8O7 |
Molecular Weight | 300.22 g/mol |
Exact Mass | 300.02700259 g/mol |
Topological Polar Surface Area (TPSA) | 132.00 Ų |
XlogP | 1.90 |
Atomic LogP (AlogP) | 1.28 |
H-Bond Acceptor | 6 |
H-Bond Donor | 4 |
Rotatable Bonds | 1 |
MLS000876948 |
NSC624610 |
4,5,7-trihydroxy-9,10-dioxoanthracene-2-carboxylic acid |
SMR000440655 |
2-Anthracenecarboxylicacid, 9,10-dihydro-4,5,7-trihydroxy-9,10-dioxo- |
4,5,7-trihydroxy-9,10-dioxo-2-anthracenecarboxylic acid |
Spectrum_000189 |
SpecPlus_000784 |
Spectrum2_000421 |
Spectrum3_001129 |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9702 | 97.02% |
Caco-2 | + | 0.5357 | 53.57% |
Blood Brain Barrier | - | 0.8250 | 82.50% |
Human oral bioavailability | + | 0.6143 | 61.43% |
Subcellular localzation | Mitochondria | 0.7631 | 76.31% |
OATP2B1 inhibitior | - | 0.6784 | 67.84% |
OATP1B1 inhibitior | + | 0.9461 | 94.61% |
OATP1B3 inhibitior | + | 0.8614 | 86.14% |
MATE1 inhibitior | - | 0.5800 | 58.00% |
OCT2 inhibitior | - | 1.0000 | 100.00% |
BSEP inhibitior | - | 0.9279 | 92.79% |
P-glycoprotein inhibitior | - | 0.9695 | 96.95% |
P-glycoprotein substrate | - | 0.9748 | 97.48% |
CYP3A4 substrate | - | 0.6594 | 65.94% |
CYP2C9 substrate | - | 0.8352 | 83.52% |
CYP2D6 substrate | - | 0.8880 | 88.80% |
CYP3A4 inhibition | - | 0.7893 | 78.93% |
CYP2C9 inhibition | - | 0.5087 | 50.87% |
CYP2C19 inhibition | - | 0.8751 | 87.51% |
CYP2D6 inhibition | - | 0.8537 | 85.37% |
CYP1A2 inhibition | - | 0.7128 | 71.28% |
CYP2C8 inhibition | - | 0.7563 | 75.63% |
CYP inhibitory promiscuity | - | 0.8676 | 86.76% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.8323 | 83.23% |
Carcinogenicity (trinary) | Non-required | 0.6289 | 62.89% |
Eye corrosion | - | 0.9944 | 99.44% |
Eye irritation | + | 0.9883 | 98.83% |
Skin irritation | + | 0.6795 | 67.95% |
Skin corrosion | - | 0.9742 | 97.42% |
Ames mutagenesis | - | 0.8000 | 80.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.8543 | 85.43% |
Micronuclear | + | 0.7900 | 79.00% |
Hepatotoxicity | + | 0.9107 | 91.07% |
skin sensitisation | - | 0.7595 | 75.95% |
Respiratory toxicity | + | 0.6667 | 66.67% |
Reproductive toxicity | - | 0.7000 | 70.00% |
Mitochondrial toxicity | + | 0.6000 | 60.00% |
Nephrotoxicity | + | 0.7844 | 78.44% |
Acute Oral Toxicity (c) | III | 0.5798 | 57.98% |
Estrogen receptor binding | + | 0.6050 | 60.50% |
Androgen receptor binding | + | 0.6725 | 67.25% |
Thyroid receptor binding | - | 0.7252 | 72.52% |
Glucocorticoid receptor binding | + | 0.6808 | 68.08% |
Aromatase binding | - | 0.7184 | 71.84% |
PPAR gamma | + | 0.6513 | 65.13% |
Honey bee toxicity | - | 0.9307 | 93.07% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | - | 0.7200 | 72.00% |
Fish aquatic toxicity | + | 0.9847 | 98.47% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] |
14125.4 nM |
Potency |
via CMAUP
|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
22387.2 nM 25118.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
35481.3 nM |
Potency |
via CMAUP
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2392 | P06746 | DNA polymerase beta |
7943.3 nM |
Potency |
via CMAUP
|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase |
14125.4 nM |
Potency |
via CMAUP
|
CHEMBL1287622 | Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 |
2511.9 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
22387.2 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
7079.5 nM 3981.1 nM 12589.3 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL1075189 | P14618 | Pyruvate kinase isozymes M1/M2 |
17782.8 nM 17782.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
10000 nM 6309.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 92.73% | 99.23% |
CHEMBL3194 | P02766 | Transthyretin | 92.14% | 90.71% |
CHEMBL2581 | P07339 | Cathepsin D | 91.47% | 98.95% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.18% | 95.56% |
CHEMBL1811 | P34995 | Prostanoid EP1 receptor | 91.09% | 95.71% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.48% | 91.11% |
CHEMBL4208 | P20618 | Proteasome component C5 | 88.97% | 90.00% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 88.56% | 89.00% |
CHEMBL3864 | Q06124 | Protein-tyrosine phosphatase 2C | 88.24% | 94.42% |
CHEMBL1929 | P47989 | Xanthine dehydrogenase | 88.15% | 96.12% |
CHEMBL5697 | Q9GZT9 | Egl nine homolog 1 | 86.40% | 93.40% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 85.48% | 91.49% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 83.28% | 86.33% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 83.09% | 91.19% |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 82.34% | 96.38% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 80.11% | 99.17% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 80.03% | 99.15% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Andrographis neesiana |
Coreopsis tinctoria |
Magnolia ovata |
PubChem | 361510 |
NPASS | NPC290550 |
ChEMBL | CHEMBL290914 |
LOTUS | LTS0140301 |
wikiData | Q27165344 |